Institutional Fund
Samsara Biocapital, LLC
Palo Alto, CACIK 17449675 filings on record
Portfolio Value
$1.03B
Q1 2026
Holdings
22
Reported positions
New Buys
3
Opened this quarter
QoQ Change
+6.2%
from $969.26M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Scholar Rock Hldg Corp32.9%
- Mineralys Therapeutics Inc15.5%
- Alumis Inc13.6%
- Septerna Inc7.4%
- Kalaris Therapeutics Inc7.3%
- Spyglass Pharma Inc5.3%
- Other18.1%
Portfolio Holdings
22 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Scholar Rock Hldg Corp | 6.90M | $339.09M | 32.9% | 0 | Held |
| 2 | Mineralys Therapeutics Inc | 5.87M | $159.05M | 15.5% | 0 | Held |
| 3 | Alumis Inc | 6.35M | $139.79M | 13.6% | +588.2K | Added |
| 4 | Septerna Inc | 3.15M | $75.67M | 7.4% | 0 | Held |
| 5 | Kalaris Therapeutics Inc | 12.95M | $74.71M | 7.3% | 0 | Held |
| 6 | Spyglass Pharma Inc | 2.11M | $54.67M | 5.3% | +2.11M | New |
| 7 | Neurogene Inc | 1.72M | $34.62M | 3.4% | 0 | Held |
| 8 | Inventiva SA | 5.19M | $28.83M | 2.8% | 0 | Held |
| 9 | Sutro Biopharma Inc | 1.06M | $26.48M | 2.6% | +858.4K | Added |
| 10 | Jade Biosciences Inc | 968.8K | $13.61M | 1.3% | 0 | Held |
12 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio